• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Carta del Rischio del PPP

Derivation of prognostic modelAvanzini et al. 200133
Location & dateItaly
Population characteristicsParticipants in RCT of aspirin and vitamin E Mean follow up 3.6 years
Inclusion, co-morbidity
Risk factorsAge (3 groups)
Sex (separate charts)
Systolic blood pressure (2 groups)
HDL cholesterol (2 groups)
Smoker (yes/no)
Diabetes (yes/no)
OutcomeCVD
Prediction period3.6 years
Statistical methodsMultivariate model
PracticalChart
Authors notes
Modifications, tools or guidelines
External validation
Convergent validation
Trials of health outcomes

From: Appendix 3, Prognostic models or risk scoring methods for use in targeting primary prevention of cardiovascular diseases (part completed)

Cover of A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement)
A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement) [Internet].
NICE Clinical Guidelines, No. 67S.
Beswick AD, Brindle P, Fahey T, et al.
Copyright © 2008, Royal College of General Practitioners.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.